©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 7, 2014; 20(29): 9775-9827
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.9775
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.9775
Table 4 Selected common polymorphisms of MDR1, GSTP1, ERCC1, ERCC2, XRCC1 genes and their potential impact on functioning of proteins related to OX pharmacology
| dbSNP rs cluster ID | Type of polymorphism | Function | Ref. |
| Multidrug resistance 1 (MDR1, ABCB1) (OMIM #171050) | |||
| rs1128503 | SNP | [152,296,318,485] | |
| 1236C>T | Synonymous, effect unknown | ||
| http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs = 1128503 | |||
| rs2032582 | SNP | [152,296] | |
| 2677G>T/A | Ser893Ala or Ser893Thr, the GG genotype carriers have the highest while the AT genotype carriers have the lowest levels of ABCB1 expression | ||
| http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs = 2032582 | |||
| rs1045642 | SNP | [152,296,350,485] | |
| 3435C>T | Synonymous, TT genotype carriers have lower intestinal ABCB1 expression | ||
| http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs = 1045642 | |||
| Glutathione S-transferase π (GSTP1) (OMIM #134660) | |||
| rs1138272 | SNP | [311,477] | |
| 341C>T | Ala114Val, altered enzyme kinetics, altered toxicity | ||
| http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs = 1138272 | |||
| rs1695 | SNP | [51,180,311-329,467,477] | |
| 313A>G | Ile105Val, decreased enzymatic activity, altered toxicity | ||
| http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs = 1695 | |||
| Excision repair cross-complementation group 1 (ERCC1) (OMIM #126380) | |||
| rs11615 | SNP | [51,313,344,345,357,486] | |
| 354T>C | Synonymous, decreased transcriptional activity of ERCC1 | ||
| http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs = 11615 | |||
| rs3212948 | SNP | [487] | |
| 321+74C>G | Intronic SNP (intron 2), protective effect of the C allele to cancer risk | ||
| http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs = 3212948 | |||
| Excision repair cross-complementation group 2 (ERCC2, XPD) (OMIM #126340) | |||
| rs13181 | SNP | [51,313,336,337,350,351,353,356,357,486] | |
| 2251A>C | Lys751Gln, the Gln allele is associated with a higher DNA adduct level or lower DNA repair capacity | ||
| http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs = 13181 | |||
| rs1799793 | SNP | [313,336,337,353] | |
| 862G>A | Asp312Asn, lower DNA repair capacity for the Asn allele than the Asp allele | ||
| http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs = 1799793 | |||
| X-ray cross complementation factor (XRCC1) (OMIM #194360) | |||
| rs25487 | SNP | [51,313,349,350,361-364,486] | |
| 1196A>G | Arg399Gln, reduced base excision repair function for Gln allele than the Arg allele | ||
| http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs = 25487 | |||
- Citation: Panczyk M. Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years. World J Gastroenterol 2014; 20(29): 9775-9827
- URL: https://www.wjgnet.com/1007-9327/full/v20/i29/9775.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i29.9775